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TheObjective: The study objective was to develop quality indicators for coronary artery
bypass graft surgery that relate to quality of care, associate with preventable death,
and could be reported on performance reports.
Methods: A comprehensive list of quality indicators was collected from quality
improvement organizations including the Society For Thoracic Surgery, Northern
New England Cardiovascular Disease Study Group, and Veteran’s Affairs System.
Indicators were collated from practice guidelines from the American College of
Cardiology and the American Heart Association. A MEDLINE search using the
keywords “quality indicators” and “coronary bypass” was completed. A 17-member
multidisciplinary international expert panel was assembled, who voted using a
2-step Delphi process regarding association with quality of care, risk adjustment,
association with preventable death, and inclusion on performance reports.
Results: A total of 149 quality indicators were examined. This list was distilled to
33 indicators related to quality of care, 10 indicators that could be adequately risk
adjusted, 34 indicators related to preventable death, and 18 indicators to be included
on performance reports. These selected indicators consisted of 19 outcome vari-
ables, 23 process of care variables, and 4 structure variables. The quality indicators
believed to be useful on a Canadian institutional coronary artery bypass graft
surgery report card included the following: 30-day mortality, in-hospital mortality,
electrocardiographic myocardial infarction, red cell transfusion, allogeneic blood
product transfusion, deep sternal wound infection, postoperative stroke, postopera-
tive dialysis, intensive care unit readmission, intensive care unit length of stay,
ventilation time, repeat cardiac operation, repeat surgery with cardiopulmonary
bypass, repeat revascularization, waiting time to surgery, completion of surgery
within a recommended waiting time, use of left internal thoracic artery graft, and
institutional volume.
Conclusions: This set of consensus quality indicators can be used as a standard list
to be monitored by providers of coronary artery bypass graft surgery in an effort to
continuously evaluate and improve their performance.
The monitoring of quality of care has been an essential part of ongoing qualityof care efforts in cardiac surgery. Risk-adjusted mortality is used as thestandard measure of quality of care to evaluate the institutional performance
for coronary artery bypass graft (CABG) surgery, despite the fact it has an uncertain
link to quality of care.1 It has been suggested that the publication of hospital
mortality may deliver the wrong message to the public about the relative perfor-
mance of a hospital, because the public is not aware of the weak evidence to date
that links mortality to quality of care.2
Quality of care as defined by the Institute of Medicine is the “degree to which
health services for individuals increases the likelihood of desired health outcomes
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For many aspects of cardiac surgical practice the health
services that increase the likelihood of desired health out-
comes are not clear. It is also apparent that health outcomes
themselves are not adequate to measure quality of care,
because they can vary with patient factors and random
chance, which cannot always be accounted in statistical
modeling.
Report cards have focused on the outcomes portion of
the Donabedian model of quality of care consisting of the
dimensions of structure, process, and outcome. Structure
includes variables related to the resources and systems
within a hospital, such as staffing ratios. Process relates to
recognized therapeutic management of a patient, for exam-
ple, the use of internal thoracic artery grafts to bypass the
left anterior descending artery. Outcomes represent adverse
clinical events that occur after the completion of CABG
surgery.
The argument for using outcomes despite scarce evi-
dence of the link to quality performance is that the goal of
clinical care is to provide a good outcome, and so the quality
of care should be mirrored in the outcome.4 Mortality is the
most common outcome that has been analyzed because of
its clear definition and the ease of availability. There has
been a need to create more comprehensive outcomes report
cards for CABG surgery that better reflect institutional
quality of care.5 Detailed report cards that include outcomes
other than mortality have not been widely researched for
CABG surgery.6
Surveys of cardiologists and cardiac surgeons have been
completed to understand the impact of these reports on
practice patterns.7,8 In Pennsylvania, only 10% of cardiac
surgeons and cardiologists in the state believed that mortal-
ity rates were “very important” in assessing surgeon perfor-
mance, and 87% of cardiologists stated the guide had a
minimal influence or none on their referral patterns.7 A
majority (78%) of cardiac surgeons and cardiologists be-
lieved the most important limitation of these reports was the
absence of indicators of quality other than mortality.7 In
Pennsylvania the CABG surgery guide had limited credi-
bility, and it was concluded that future reports should be
collaborative and involve all stakeholders.7 It is more likely
that reports tailored and targeted to providers will be suc-
cessful in influencing improvements in the quality of care.
In the United States, peer review organizations monitor
Abbreviations and Acronyms
CABG coronary artery bypass graft
ECG  electrocardiogram (electrocardiographic)
ICU  intensive care unit
NQF  National Quality Forumhospital use and quality of care in many states with the goals
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through the identification of preventable mortality and mor-
bidity by implicit chart reviews. These reviews identify
outcomes that are related to quality of care and would be
preventable if optimal care had been delivered.9 This type of
review is the most accurate estimate of the proportion of
adverse outcomes related to quality of care; however, the
use of this process is limited because it is costly and time
consuming.
The National Quality Forum (NQF), a private, nonprofit,
public benefit corporation whose mission is to improve
American health care, recently released a report of volun-
tary consensus standards for cardiac surgery.10 Previous to
this there was no consensus set of quality measures or
indicators that had been published for CABG surgery. The
method of identifying quality indicators in health care
through consensus paneling has been successfully applied in
many situations including hospital admissions for conges-
tive heart failure and acute myocardial infarction, as well as
for emergency visits.11-13 This project’s goal was to develop
a comprehensive set of consensus indicators for CABG
surgery that was believed by an expert panel to measure
quality of care, relate to preventable death, and be included
as a minimum set on Canadian CABG performance
reports.
Methods
Quality Indicators
An initial list of potential quality indicators was accumulated
through a MEDLINE search, databases of established quality
initiatives (eg, Northern New England Cardiovascular Disease
Study Group, Society For Thoracic Surgeons), American College
of Cardiology/American Heart Association guidelines, and expert
opinion.14-19 The literature search focused on randomized con-
trolled trial evidence. Quality indicators included variables that
were outcomes, surrogate outcomes related to processes of peri-
operative care, and structure variables. These variables were rated
on 5-point Likert scales, and panel members were given an op-
portunity to suggest quality indicators that were not listed.
Rating Scales
Outcomes and surrogate outcomes (such as peak troponin level
and lowest intraoperative hematocrit) were rated on 4 separate
scales. The first scale evaluated the degree to which the imple-
mentation of best practice evidence and guidelines could help
prevent the outcome (1  extremely preventable, 2  very pre-
ventable, 3  somewhat preventable, 4  minimally preventable,
5  not at all preventable). The second scale evaluated the ade-
quacy of risk adjustment for this outcome (1  extremely ade-
quate, 2  very adequate, 3  neutral, 4  minimally adequate, 5
 not adequate). The third scale evaluated whether the outcome
was related to preventable death (1  strongly related, 2  very
related, 3  somewhat related, 4  minimally related, 5  not at
all related). The final scale evaluated the usefulness of the outcome
to be used on a surgery report card for institutional quality assur-
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useful, 4  minimally useful, 5  not at all useful).
The process of care variables and structure variables were rated
on 3 separate scales. The first scale evaluated whether the process
or structure variable was related to preventing adverse outcomes
after CABG surgery (1  strongly related, 2  very related, 3 
somewhat related, 4  minimally related, 5  not at all related).
The second scale evaluated whether the process or structure vari-
able was related to preventable death (1  strongly related, 2 
very related, 3  somewhat related, 4  minimally related, 5 
not at all related). The third scale evaluated how useful it would be
to measure process or structure variables on CABG surgery report
cards for institutional quality assurance (1 extremely useful, 2
very useful, 3  somewhat useful, 4  minimally useful, 5  not
at all useful).
Delphi Consensus Panel
Delphi consensus paneling is a process that involves consulting a
group of experts on an issue.20 Through multiple ratings with
anonymous feedback between rounds of ratings (including provid-
ing their response to questions in relation to the panel’s response),
a clear consensus on the issue is reached.20 Our panel consisted of
19 members who were multidisciplinary, including cardiac sur-
geons from 10 hospitals in Ontario and Quebec, 2 cardiac anes-
thetists, 1 US surgeon (Frederick Grover) involved in quality
initiatives of the Society for Thoracic Surgery and Veteran’s
Affairs system, 1 outcomes researcher from Alberta, and a quality
of care researcher (Gerald T. O’Connor) heading quality initiatives
TABLE 1. Consensus Quality Indicators to be reported on
Percentage agreemen
Quality indicator Qu
Outcomes
30-day mortality
In-hospital mortality
Postoperative stroke
Postoperative ECG myocardial infarction
Deep sternal wound infection
Postoperative dialysis
Chest reopening
ICU readmission
Ventilation time
ICU length of stay
Total packed red blood cells transfused
Total units of allogeneic blood products
365-day repeat operation with CPB
365-day repeat revascularization
Processes of care
Waiting time to surgery
Completion of surgery within a recommended waiting time
Internal thoracic artery to LAD
Structure
Institutional volume
ECG, Electrocardiogram; ICU, intensive care unit; CPB, cardiopulmonary by
on this scale. †Rating scale not applicable to this variable.in the Northern New England region. Nominations for members of
The Journal of Thoracic anthe panel were requested from the Heart and Stroke Foundation of
Canada and the Canadian Cardiovascular Society. The panel rated
all potential quality indicators during the first round through an
e-mail survey, and a second rating was completed after each
variable was discussed at a full day meeting. Those variables on
which two thirds of the panel reached a consensus that there was
a relation to quality of care, relation to preventable death, and/or
need for inclusion on a surgical report card were developed further.
The definitions of the chosen quality indicators were then dis-
cussed and clarified by the panel through a series of four 1-hour
teleconferences. The quality indicators derived from our panel
were also compared with the list derived from the NQF’s voluntary
standards consensus report on cardiac surgery.
Results
This report includes a summary of the results of the con-
sensus panel discussion of quality measures. Detailed indi-
cator definitions are available at http://www.qualitycabg.org
for readers who would like to use them for CABG surgery
databases or CABG surgery institutional performance pro-
filing. The quality measures that were evaluated in the
consensus process were classified into major categories
including outcomes, processes of care, and structure vari-
ables. Preventable death was considered the most important
quality measure, and all other potential quality indicators
were rated regarding their relation to this important variable.
nary artery bypass graft surgery institutional report cards
various rating scales
of care Preventable death Report card Risk adjustment
% 87% 100% 100%
% 100% 100% 100%
% 93% 100% 93%
87% 80% *
% 100% 100% 67%
80% 87% 73%
73% 67% *
* 67% 73%
* 69% *
% * 87% 87%
% 73% 73% *
% 79% 79% *
73% 73% *
* 67% *
67% 87% †
% 80% 80% †
% 100% 87% †
* 67% †
LAD, left anterior descending. *Less than two thirds reached a consensuscoro
t for
ality
73
93
67
*
93
*
*
*
*
80
73
79
*
*
*
67
100
*
pass;A total of 149 potential quality indicators were evaluated in
d Cardiovascular Surgery ● Volume 130, Number 5 1257.e3
nary b
Surgery for Acquired Cardiovascular Disease Guru et althis Delphi process including 54 outcome variables, 20
surrogate outcome variables, 72 process of care vari-
ables, and 3 structure variables.
A total of 18 variables were agreed on as important
enough to be included on an institutional performance re-
port for CABG surgery (Table 1). This included 14 outcome
variables, 3 process of care variables, and 1 structure vari-
able (Table 1). It was interesting to note that both 30-day
mortality, which takes into account out-of-hospital mortal-
ity at a specific time-point, and in-hospital mortality were
considered important as separate measures of quality (Table 1).
TABLE 2. Comparison of Canadian Consensus Quality Indi
National Quality Forum Voluntary C
Quality indicator Canadian Con
Structure
Participation in a cardiac surgery database Encouraged
Case volume Institutional volume
Processes of care
Timing of antibiotic administration Not included
Selection of antibiotic administration Not included
Duration of antibiotic prophylaxis Not included
Preoperative beta-blockade Not included
Internal thoracic artery use If bypassed to LAD
Waiting time to surgery Included
Completion of surgery within a
recommendedwaiting time according to
patient’s symptoms
Included
Antiplatelet medications at discharge Not included
Beta-blockade at discharge Not included
Anti-lipid treatment at discharge Not included
Outcomes
30-day mortality Included
In-hospital mortality Included
Operative mortality (AVR) Valve surgery not i
Operative mortality (MVR) Valve surgery not i
Operative mortality (MVRCABG) Valve surgery not i
Operative mortality (AVRCABG) Valve surgery not i
Ventilation time Included
ICU length of stay Included
Chest reopening Included
ICU readmission Included
Postoperative stroke Included
Postoperative ECG myocardial infarction Included
Deep sternal wound infection Included
Postoperative dialysis Included
Total packed red blood cells transfused Included
Total units of blood products transfused Included
365-day repeat operation with CPB Included
365-day repeat revascularization Included
NQF, National Quality Forum; AVR, aortic valve replacement; MVR, mitral v
LAD, left anterior descending; ECG, electrocardiogram; CPB, cardiopulmoThese measures were rated highly for all rating scales and
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report cards (Table 1).
For measures such as ventilation time, intensive care unit
(ICU) readmission, 365-day repeat revascularization, and
institutional volume, there was a consensus regarding inclu-
sion in an institutional performance report; however, there
was no consensus on their relation to quality of care and
preventable death (Table 1). There was no consensus whether
robust risk-adjustment was available for some outcomes that
were otherwise believed by the panel to be important enough
to include on report cards, including postoperative electro-
rs for standardized reporting in relation to
sus Standards for cardiac surgery
s Panel NQF Consensus Standards
Encouraged
Volume for CABG, valve, and CABG  valve
surgery
Included
Included
Included
Included
ry Included
Not included
Not included
Included
Included
Included
Included but also indicates all in-hospital deaths
regardless of timing
Included
ed in project Included
ed in project Included
ed in project Included
ed in project Included
Included as prolonged intubation
Not included
Included as surgical reexploration
Not included
Included
Not included
Included
Included as postoperative renal insufficiency
Not included
Not included
Not included
Not included
eplacement; CABG, coronary artery bypass graft; ICU, intensive care unit;
ypass.cato
onsen
sensu
arte
nclud
nclud
nclud
nclud
alve rcardiographic (ECG) myocardial infarction, ventilation
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products transfused, ICU length of stay, chest reopening,
365-day repeat operation with cardiopulmonary bypass, and
365-day repeat revascularization (Table 1).
The process of care variables that it was agreed should be
reported included waiting time to surgery and completion of
surgery within a recommended waiting time depending on
the triage urgency of a case (Table 1). These measures are
important in the Canadian public health care system in
which resource constraints lead to waits for invasive proce-
dures. The only other process of care that was agreed should
be reported was the use of the internal thoracic artery in left
anterior descending bypass surgery (Table 1).
The variables selected by our panel as appropriate for
TABLE 3. Coronary artery bypass graft surgery quality indic
on which no consensus was reached for use in an institu
Percentage agreemen
Quality indicator
Outcomes
Postoperative length of stay
New postoperative IABP
Inotropic support required at 24 and 48 h
Postoperative cardiac arrest
Reintubation rate
Processes of care
IV nitroglycerin until time of OR for CCS IV angina
Continue IV heparin or LMWH until OR for recent ACS
Stop ADP inhibitors preoperatively
Continue ASA until OR for elective patients
Timely administration of preoperative prophylactic antibiotics
Administration of antifibrinolytics for reoperative CABG surgery
TEE at the beginning and end of every case
Assessment of aorta by epiaortic ultrasound
Complete revascularization
Assessment of graft patency at the end of every case
Myocardial protection with blood cardioplegia
Initiation of ASA or other antiplatelet within 24 h postoperatively
Insulin infusion initiated within 24 h for elevated glucose level
Initiation of beta-blocker
Continuous telemetry monitoring on the ward
Postoperative ASA administered
Anticoagulation with heparin for 48 h of atrial fibrillation
Postoperative beta-blocker administered
Postoperative antihyperlipidemic administered
Postoperative ACE inhibitor administered
Structure
Nurse to patient ratio in the ICU
Nurse to patient ratio on the ward
Daily ward care managed by dedicated NP or MD
IABP, Intra-aortic balloon pump; OR, operating room; CCS, Canadian Card
heparin; ADP, adenosine diphosphate platelet receptor; ASA, acetylsalic
enzyme; ICU, intensive care unit; NP, nurse practitioner; ACS, acute corona
a consensus on this scale. †Rating scale not applicable to this variable.reporting on institutional report cards were further com-
The Journal of Thoracic anpared with the NQF’s consensus standards for cardiac sur-
gery list (Table 2). It is interesting to note that 50% of the
quality indicators selected for reporting by our panel over-
lapped with the NQF’s voluntary standards (Table 2). The
NQF’s set included a number of process variables that were
not selected by our panel (despite being reviewed during the
Delphi process), including the type and timing of preop-
erative antibiotics, the perioperative use of beta blockade,
and the postoperative use of antiplatelet agents and lipid-
lowering agents (Table 2). The NQF’s set of standards
included valve-related outcomes, which were not in the scope
of our project (Table 2). Conversely the NQF’s standards did
not include variables unique to a public health care system
including waiting time to surgery and surgery within a recom-
s rated highly for quality of care and/or preventable death
l performance report
various rating scales
Quality of care Preventable death Risk Adjustment
67% * 73%
* 67% 67%
* 80% 80%
* 80% *
92% 86% *
67% * †
* 67% †
67% * †
73% 67% †
93% 70% †
80% * †
73% 73% †
80% 73% †
87% 80% †
93% 87% †
80% 73% †
87% 73% †
87% 73% †
67% * †
67% * †
80% 73% †
87% 80% †
93% 87% †
87% 91% †
87% 91% †
87% 80% †
87% 80% †
67% * †
ular Society angina class; IV, intravenous; LMWH, low molecular weight
cid; TEE, transesophageal echocardiogram; ACE, angiotensin-converting
drome; CABG, coronary artery bypass graft. *Less than two thirds reachedator
tiona
t for
iovasc
ylic a
ry synmended waiting time based on a patient’s symptomatic
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Canadian panel included as important in measuring in-
stitutional performance that the NQF’s set did not in-
clude, such as 1-year repeat revascularization, perioper-
ative rates of allogeneic blood transfusion, postoperative
ECG myocardial infarction, and ICU readmissions and
length of stay.
There were variables that despite being labeled by the
panel as related to quality of care, preventable death, or both
were not included in those chosen for institutional reporting.
Some of these were process of care variables that the NQF
included in their set (Table 3). It was interesting that hos-
pital length of stay was one of these variables, despite the
fact it had been used as a standard measure for CABG
surgery reports in Ontario in the past.
There were a number of variables that by consensus were
believed to be related both to quality of care and preventable
death but were not believed to be useful on an institutional
report card (Table 3). Many of these were process and
structure variables in which the requirement of technology
or staffing was not monetarily feasible within a publicly
funded hospital budget, such as the use of transesophageal
echocardiograms at the beginning and end of each case,
assessment of the aorta by epiaortic ultrasound, intraopera-
tive assessment of graft patency, nurse to patient ratio in the
ICU, and nurse to patient ratio on the ward. These variables
were believed to be important to measure to understand
where it may be necessary to lobby for funding; however, the
panel agreed reporting at an institutional level would only be
reflective of the public funding available to a particular surgical
service, and not necessarily the performance.
Other variables (Table 3) that were believed to be related
both to quality of care and preventable death were mainly
medication administration processes of care, including the
use of preoperative aspirin until the day of surgery for
elective patients, timely administration of prophylactic pre-
operative antibiotics to prevent wound infection, initiation
of aspirin or other antiplatelet within 24 hours after surgery,
insulin infusion initiation within 24 hours of surgery for
elevated glucose, postoperative aspirin use, anticoagulation
for patients with episodes of atrial fibrillation that continue
over a 48-hour period, postoperative beta-blocker use, postop-
erative antihyperlipidemic use, and postoperative angiotensin-
converting enzyme inhibitor use.
The intraoperative variables that were believed to be
important both for preventable death and quality of care
included complete revascularization and blood cardioplegia.
Discussion
We hope this set of quality indicators for CABG surgery
will serve as a feasible, standard list that will be monitored
by providers of CABG surgery in an effort to continuously
evaluate and improve their performance in Canada. After
1257.e6 The Journal of Thoracic and Cardiovascular Surgery ● Nthe evaluation of an extensive list of potential indicators we
were able to narrow down the variables to measures that
were agreed as most important to collect and report. Many
of the variables included in this set can be derived from
existing clinical and administrative databases, an important
consideration in a public health care system with limited
funding available for such activities. In addition, we hope
to abstract those variables that are not currently available
in any database on an ongoing basis through chart ab-
straction in a regional initiative to improve quality of care
in Ontario.
The set of quality indicators that we developed include a
broad range of all aspects of the Donabedian model of
health care including outcomes, process, and structure vari-
ables related to CABG surgery. We have distinctly defined
which indicators the majority of an expert panel agree relate
to the concrete concept of the Institute of Medicine’s defi-
nition of quality of care and another important measure of
quality, namely, preventable death.21-23 The panel also took
into consideration that this quality indicator set was to be
applied in the unique setting of public health care, where
resource constraints lead to queuing for procedures and
efficiency is a crucial quality measure in allowing surgical
services to move patients through the system.
The primary intent in developing this quality indicator
set was to encourage providers to voluntarily collect and
report their outcomes as has occurred for basic outcomes in
the province of Ontario. We anticipate with limited capacity
for cardiac surgical services and little consumer choice,
quality initiatives will serve to provide public accountability
and encourage provider quality improvement. However,
because of a lack of excess services it is unlikely that
consumers will shift to higher performing providers in Can-
ada. In our country there have been no mandatory outcomes
reporting initiatives, and public reporting only exists at an
institutional level in one province (ie, Ontario). Because
quality improvement initiatives in Canada are voluntary,
there has been no pressure to report outcomes at a surgeon
level.
Our panel was instructed to select an ideal set of mea-
sures that could be used to assess quality of care, were
feasible to collect, and could be included in yearly institu-
tional cardiac surgery report cards. Despite the fact our
clinicians believed that process measures, such as those
selected in the NQF process, were related to quality of care
and preventable death, they ultimately prioritized a set of
measures that included mainly outcome measures. Our
panel thought outcomes feedback would be most useful to
providers in measuring institutional performance. Our panel
further thought that in the absence of clear randomized trial
evidence for the timing, and perioperative use of many
process measures, it would not provide the most impact in
guiding providers toward a need for quality improvement.
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to support the process measures contained in the NQF set,
and these process measures are widely used by many
clinicians.
The Delphi consensus expert panel process involving
both providers and health care research methodologists was
used to develop these indicators to ensure their clinical
relevancy and importance in relating to quality of care.13 It
has been suggested and shown that providers of CABG
surgery, where established public reporting has existed for
years, are ambivalent to these reports, and this may be
because of limited stakeholder involvement in the process
of measuring and reporting quality of care. Regions such as
New York State and Pennsylvania are examples where
governmental decree has led to the production of CABG
surgery reports that contain quality measures limited to
mortality, length of stay, and readmission to hospital.7,8 The
perspective of our panel was mainly to target quality im-
provement in providers through feedback, rather than shift-
ing consumers to those providers with better outcomes. It is
interesting to note that the NQF panel included purchasers,
consumers, and payors in addition to providers, which could
explain the difference in the composition of their set of
quality measures. The NQF panel stipulated that the mea-
sures to be included in their set must already be widely
accepted and in use by providers.
The measurement and reporting of quality indicators in
CABG surgery has been identified as vital in improving
quality of care as reflected by improvements observed in
regions where this has already been implemented.14,15,24-27 We
recognize the set of quality measures selected in this study
will require update with evolving evidence and may need to
be modified because of regional differences in the delivery
of CABG care. Despite this caveat, it is reassuring to
observe there was a significant degree of overlap in the
quality indicators selected in our study in comparison with
the NQF process of voluntary consensus standards for car-
diac surgery in the United States.
The derivation of quality indicators in our study was in
the context of CABG surgery in a public health care system,
such as Canada. To this endeavor our set of quality indica-
tors included “waiting time to surgery” and “completion of
surgery within a maximum recommended waiting time,”
measures that would not be an issue in most regions of the
United States. These measures were included to monitor for
deficiencies in the capacity of our health care system (ie, not
an institutional problem but a governmental health care
funding issue) and to ensure that all institutions efficiently
direct patients through the queue for surgery, including
transferring patients to other institutions to receive surgery
in a timely fashion. All other measures were defined in a
way to ensure they were consistent with existing databases
including The Society for Thoracic Surgery database.
The Journal of Thoracic anOther unique aspects of our set include our ability to
track patients out to 1 year after surgery using administra-
tive databases available in the Canadian public health care
system. Thus, our panel decided to include measures such as
“365-day repeat surgery requiring cardiopulmonary bypass”
and “repeat revascularization.” These measures span be-
yond the classic in-hospital outcomes and measure the du-
rability of a surgical treatment. Such measures can be in-
fluenced by a variety of factors including the technical
quality of the surgery, effectiveness of the procedure includ-
ing the choice of patient, and quality of postoperative care.
In the United States, such measures may also be of interest
to payors and purchasers of health care in assessing the
relative value of a treatment choice, especially because
currently the evidence is not clear on whether multivessel
angioplasty may be superior to CABG. In Canada, provin-
cial governments are in control of healthcare dollars and
frequently use observational data to plan healthcare fund-
ing, including the relative distribution of funds to various
hospital programs.
The challenge with many of our outcome quality mea-
sures is that robust risk adjustment is not currently available.
This was recognized by the panel and will require further
investigation. A further consideration is the ease of inter-
pretation of the quality measure. The NQF set of measures
included a larger proportion of process measures that are
easier to define and report, and do not require risk adjust-
ment other than the exclusion of ineligible patients. On the
other hand, outcome measures require risk adjustment and
may be harder to translate to the lay public. Because our set
mainly includes outcomes, we will have to provide a trans-
lational document to assist with the interpretation of such
data by more general audiences. We further hope to be able
to provide the relationships between the different categories
of quality indicators, and thus a more accurate snapshot of
quality at an institutional level.
A limitation of our study was that during the panel
process members may have been biased in choosing certain
indicators for inclusion. However, we suspect these biases
would be minimized because of the multidisciplinary nature
of the panel (ie, a diverse range of participants including
providers, Canadian and US members, and health policy
methodologists). During the panel process, the panel was
allowed to freely suggest, discuss, and add further quality
measures to the initial list.
Conclusion
We used a formal process to identify and define quality
indicators that are most important to monitor quality of care
for CABG surgery in a continuous quality improvement
effort. We hope this set of indicators will be a useful starting
point for individual surgeons or hospitals as well as regions
interested in embarking on initiating a continuous quality
d Cardiovascular Surgery ● Volume 130, Number 5 1257.e7
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for CABG surgery. In our region we will be testing the
feasibility of measuring these indicators and hope to even-
tually set indicator benchmarks regarding performance that
our hospitals can aim to strive toward.
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Project (Funded by a Research Grant From the
Heart and Stroke Foundation of Ontario HSF 5484)
Appendix of Definitions†
*Those indicators recommended by the consensus panel members
to be collected and included in CABG surgery performance reports
for the purpose of quality improvement. The remaining indicators
were rated by the panel as significantly related to quality of care
and/or preventable death following CABG surgery
Outcomes
*30-day mortality: Any death occurring within 30 days fol-
lowing the operative date.
*In-hospital mortality: A death occurring at any point during
the hospital stay.
Hospital postoperative length of stay: The total number of
days spent in hospital from the date of surgery to the date of
discharge home, or transfer to another acute care facility/long-term
care facility. The variables to be collected include: date of surgery,
date of discharge, and discharged to either (1) home, (2) acute care
facility, (3) long term care facility (this information must be chart
abstracted).
The following outcome is for measurement during the
intraoperative time period only:
Reinstitution of CPB after initial separation: The require-
ment to put a patient back on cardiopulmonary bypass as indicated
by the perfusion records through the following flags: administra-
tion of protamine, full reheparinization, and reinitiation of cardio-
pulmonary bypass.
The following outcomes are for measurement during
the in-hospital time period only:
New postoperative intra-aortic balloon support: The inser-
tion of an intra-aortic balloon pump at any point after grafting the
heart including intraoperatively and in the intensive care unit
(administrative data will only indicate if the balloon was inserted
on the day of surgery or after this day).
Inotropic support requirement at 24 and 48 hours: The
postoperative usage of two or more inotropes at 24 and 48 hours
after the operation in doses to maintain adequate hemodynamic
support (systolic bp  90 mm Hg, C.I.  2.2, U.O.  0.5
cc/kg/hr). The names and doses of the inotrope infusions will be
abstracted as well as the: cardiac index, cardiac output, weight,
height, average urine output over the last 8 hours, and blood
pressure (systolic/diastolic) for these time points (eg, dobutamine,
dopamine, epinephrine, phenylephrine, norepinephrine, vasopres-
sin, milrinone).
*Postoperative in-hospital myocardial infarction ECG cri-
teria: This will measure an ECG established myocardial infarction
(must be a change from the initial preoperative ECG, excluding
those patients with a preoperative bundle branch block or paced
rhythm). Established myocardial infarction is defined as either (1)
new onset left bundle branch block, (2) loss of R waves in the
anterior leads, (3) any Q wave in leads V1 through V3, Q wave 
to 30 ms (0.03 s) in leads I, II, aVL, aVF, V4, V5 or V6. (The Q
†Available on Web site at http://www.qualitycabg.org.
The Journal of Thoracic anwave changes must be present in any two contiguous leads, and be
 1 mm in depth.) A preoperative ECG will be compared to the
latest ECG before discharge from hospital (the date of each ECG
will be included in this variable).
Postoperative cardiac arrest on the ward: An incident when
a patient is on the ward, where the arrest team is called (either for
a respiratory arrest or rhythm with inadequate blood pressure)
resulting in the need of defibrillation, chest compressions and/or
ventilatory support.
*Ventilation time: The number of hours during which the
patient has an endotracheal tube or tracheostomy with ventilation
(ie includes from the time noted at the end of skin closure to the
time of removal of the endotracheal tube from the patient and any
reintubation ventilation times).
Reintubation rate: The requirement for a patient to be rein-
tubated after initial extubation following surgery at any point
during the hospital stay.
*Total units of packed red blood cells transfused: The total
number of units of packed red blood cells transfused intraopera-
tively and postoperatively during the hospital stay. Administrative
data can only capture if red cells were transfused during the
admission.
*Total units of allogeneic blood products transfused: The
total number of units of allogeneic blood products (other than
packed red blood cells) transfused intraoperatively and postoper-
atively during the hospital stay. Administrative data can only
capture if any allogeneic blood products were transfused.
*Deep sternal wound infection including mediastinitis/os-
teomyelitis: A sternal wound infection involving the deep soft
tissues (eg, fascial, muscle, bone and/or mediastinum) with any
one of the following conditions: (1) purulent drainage from deep
incision; (2) wound opened either spontaneously or by a surgeon
with the patient having one of the following signs or symptoms:
fever  38°C, or localized pain/tenderness, unless incision is
culture negative; (3) an abscess or other evidence of infection
involving the deep incision is found on direct examination, during
reoperation or by histopathologic or radiologic examination; (4)
diagnosis of deep incisional surgical site infection by a surgeon or
attending physician.
*New postoperative stroke: A central neurologic deficit per-
sisting postoperatively for72 hours with evidence on an imaging
study (ie CT scan, MRI) and/or neurologist confirmation.
*New requirement for postoperative dialysis: A new post-
operative requirement for hemodialysis (including any new renal
replacement therapy—CRRT, CVVHD) at any time during the
hospital stay (ie, patients are excluded if they have had preopera-
tive dialysis or isolated intraoperative dialysis).
*ICU readmission: The requirement of a patient to be trans-
ferred to the intensive care unit after initial discharge to the ward
(not including step down units, including date of readmission and
date of discharge).
*Intensive care unit length of stay: The total number of days
spent in the intensive care unit after surgery (not including step
down unit stays) including readmission stays to the ICU (include
date of initial discharge from ICU).
*Chest reopening for any reason: Requirement of chest re-
opening after surgery (ie after the patient has left the OR) for any
reason (the reason will be abstracted: [1] suspected intrathoracic
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[5] low output syndrome, [6] sternal rewiring/debridement, [7]
other:reason to be listed) during a patient’s hospital stay.
The following outcomes are for measurement in those
patients that are discharged alive:
*365-day repeat cardiac operation requiring cardiopulmo-
nary bypass: A reoperation within 365 days of the surgery post
discharge identified through billing codes for cardiopulmonary
bypass, and/or repeat coronary bypass operation.
*365-day repeat revascularization—angioplasty: An angio-
plasty procedure within 365 days of the surgery (post discharge)
identified through the billing code for angioplasty.
365-day myocardial infarction: Applicable to those patients
discharged alive and readmitted to hospital as identified from
ICD-9 or ICD-10 codes for myocardial infarction.
365-day readmission for cardiac diagnosis (MI, UA, CHF):
A readmission to hospital for the primary diagnosis of myocardial
infarction, unstable angina or congestive heart failure within 365
days of the surgery post discharge identified through ICD-9 or
ICD-10 codes.
30-day all cause readmission rate: Applicable to those pa-
tients discharged alive and readmitted to hospital as identified from
ICD-9 or ICD-10 codes.
Intra-aortic balloon pump (ie severe LV dysfunction/shock/
persisting anginal symptoms): The preoperative insertion of an
intra-aortic balloon pump before grafting or precardiopulmonary
bypass for any reason (the reason for insertion will be recorded:
hemodynamic instability, severe left ventricular dysfunction (EF
 20%) and/or unstable angina not alleviated by maximal medical
therapy).
IV nitroglycerin until time of surgery if patient has CCS
Class IV angina (if bp permits): The continuation of nitrogyl-
cerin (IV, PO, TD) in those patients having angina at rest with
maximal medical therapy and an adequate blood pressure without
a requirement for inotropic or intra-aortic balloon support.
Continue IV heparin/LMWH until time of OR for those
with recent ACS (eg MI, UA): The continuation of intravenous
heparin or low molecular weight heparin (ie, dalteparin should be
stopped 12 hours in advance, enoxaparin should be stopped 24
hours in advance) until the time of OR in those patients who are
having surgery during the same hospital stay as an admission for
an acute coronary syndrome.
Stop ADP inhbitors: The stoppage for urgent and elective
patients of: ADP inhibitors (adenosine diphosphate inhibitors eg
ticlopidine) at time of the decision for urgent surgery (if 5 days
from planned date of surgery) or 5 days before planned elective
surgery date (the preoperative use of Plavix and the date that
Plavix is stopped will be abstracted).
Continue ASA until day of surgery for elective patients: The
continuation of aspirin (ASA) until the day of surgery in those
patients who are having elective surgery (this excludes those
patients that have an absolute contraindication to aspirin; ie, al-
lergy, gastic ulcer, or other physician-stated reason). The preop-
erative usage of aspirin will be recorded as well as the date that
aspirin was stopped by the patient.
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*Waiting time to surgery (ie, OR date from time of referral
to surgery): The number of days between the surgical referral
date, surgical acceptance date, and the operative date.
*Facility responsiveness (CABG completed within recom-
mended waiting time): If the surgery was completed within the
Cardiac Care Network (CCN) of Ontario’s recommended waiting
time, based on the relative urgency of the patient’s clinical status.
Timely administration of wound infection prophylactic an-
tibiotics (within 30 minutes of incision and again if the OR
exceeds 3-4 hours): The administration of the appropriate antibi-
otic choice (ie, cephalosporin or vancomycin for penicillin allergy)
within 30 minutes of the skin incision for every patient undergoing
CABG surgery (document the time antibiotics given intraopera-
tively in relation to skin incision time—a maximum of two doses
will be recorded, for those who are penicillin allergic and receive
vancomycin a second dose will not be required).
Administration of antifibrinolytics for reoperative CABG
surgery: The administration of aprotinin or transexamic acid for
patients undergoing reoperative CABG surgery to minimize blood
loss.
TEE at beginning and end of case for every patient: The use
of intraoperative transesophageal echocardiography to monitor
ventricular function, aortic disease, and mitral valve competency at
the beginning and end of the case.
Assessment of aorta (ie, by epiaortic ultrasound scanning):
The assessment of the aorta before cannulation to avoid athero-
sclerotic  calcified plaques by epiaortic ultrasound scanning.
Internal mammary artery to LAD if no absolute contrain-
dication: The use of an internal mammary artery (the type of
grafts either right or left, in-situ or free will be recorded) to bypass
the territory supplied by the left anterior descending coronary
artery in a patient with no absolute contraindications where the
IMA is unavailable (the reason for it being unavailable will be
recorded including the options of injury and previous usage at
primary CABG).
Complete revascularization: The grafting of all major terri-
tories of coronary artery circulation where there is a significant
stenosis present (the assessment includes: coronary dominance,
anatomy of significant stenoses defined as those 70% except for
left main where a significant stenosis is 50%).
Assessment of graft patency/flow: The assessment of the flow
or patency of grafts intraoperatively using either Doppler study,
TEE, or intraoperative angiography.
Myocardial protection with blood cardioplegia: The use of
blood cardioplegia to provide optimal myocardial protection dur-
ing crossclamping for those patients undergoing on-pump CABG.
CPB time: The time in minutes spent on cardiopulmonary
bypass during the initial surgery.
Initiation of aspirin (or other antiplatelet) within 24 hours
following surgery: The use of aspirin or ADP inhibitor (if ASA
not tolerated) within 24 hours following bypass surgery involving
vein grafts (ie, the time and date of the first dose of postoperative
ASA will be recorded).
Insulin infusion postop (for diagnosed and undiagnosed
diabetics) within 24 hours of surgery: The initiation of an insulin
infusion in the ICU for those patients with a random blood glucose
of 11.1 mmol/L within 24 hours following surgery (ie, the time
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as well as peak glucose level in this time period).
Initiation of beta-blocker: The use of beta-blockers within the
24 hours following surgery if no absolute contraindications were
present including: patient with cardiogenic shock (including ino-
trope or IABP use) or systolic bp  100 mm Hg, severe docu-
mented COPD, active asthma, bradycardia (HR  50/min or
symptomatic bradycardia), conduction disorder (ie, second- or
third-degree heart block), CHF with left ventricular dysfunction, or
physician documentation of other contraindication (ie the preop-
erative use of beta-blocker will be documented as well as the time
and date of initiation of postoperative beta blocker usage).
Continuous telemetry: The use of continuous telemetry mon-
itoring of CABG patients at least until 24 hours before discharge
(ie, for patient’s with average length of stay).
Aspirin: The prescription of aspirin or antithrombotic (ie,
warfarin) in-hospital on the ward and on discharge from hospital or
other antiplatelet if the patient has an absolute contraindication (ie,
allergy, gastic ulcer, or other physician-stated reason).
Anticoagulation with intravenous heparin at 48 hours after
initiation of atrial fibrillation: The initiation of full anticoagula-
tion with heparin, low molecular weight heparin or equivalent (ie,
in case of HIT) after sustained atrial fibrillation 48 hours.
Beta-blocker: The prescription of a beta-blocker in-hospital on
the ward and/or on discharge from hospital except for the follow-
ing contraindications: systolic bp  100 mm Hg, severe docu-
The Journal of Thoracic andmented COPD, active asthma, bradycardia (HR  50/min or
symptomatic bradycardia), conduction disorder (ie, second- or
third-degree heart block), CHF with left ventricular dysfunction, or
physician documentation of other contraindication (ie, the preop-
erative use of beta-blocker will be documented as well as the time
and date of initiation of postoperative beta-blocker usage).
Antihyperlipidemic: The prescription of an antihyperlipi-
demic in-hospital on the ward and/or on discharge from hospital.
ACE inhibitor: The prescription of an ACE inhibitor or an-
giotensin II receptor blocker in-hospital on the ward and/or on
discharge from hospital.
Structure
*Institutional volume: The institutional yearly volume of
CABG procedures.
Nursing to patient ratio in the ICU: The minimum ratio of
nurses to patients on average in the ICU for each institution (if this
varies greatly—the range and reasons for variation).
Nursing to patient ratio on the ward: The minimum ratio of
nurses to patients on average on the ward for each institution (if
this varies greatly—the range and reasons for variation).
Daily ward care managed by dedicated nurse practitioners
or family physicians: The use of designated care providers on the
floor that manage day-to-day postoperative care (ie, the providers
involved in care will be recorded; ie. nurse practitioners, family
physicians, residents, staff, surgical assistants).
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